Em busca de novos tratamentos para a fibrose pulmonar idiopática
DOI:
https://doi.org/10.59057/iberoleon.20075316.202440746Palavras-chave:
envelhecimento, fibrose pulmonar idiopática, matriz extracelular, senescência celular, qualidade de vidaResumo
A fibrose pulmonar idiopática (FPI) é uma doença progressiva e letal de etiologia desconhecida, cujas opções terapêuticas atuais geram efeitos colaterais significativos e não conseguem reverter a perda funcional pulmonar. Este artigo explora os avanços recentes no desenvolvimento de tratamentos mais eficazes, destacando três abordagens inovadoras: (1) fármacos que modulam os sinais mecânicos da matriz extracelular, essenciais para a progressão da fibrose; (2) terapias direcionadas a eliminar células senescentes ou mitigar seu impacto por meio de senolíticos e senomórficos; e (3) novos compostos em fase clínica, como um agonista do receptor de angiotensina II e um inibidor da via Hedgehog, que demonstraram, pela primeira vez, melhorias na função pulmonar com efeitos colaterais mínimos. O artigo conecta esses avanços terapêuticos a descobertas moleculares recentes, destacando a importância de compreender os mecanismos do envelhecimento celular, como a senescência e a disfunção mitocondrial, na patogênese da FPI. Além disso, analisa como esses achados podem ser traduzidos em opções farmacológicas mais seguras e eficazes. Ao integrar perspectivas básicas e clínicas, o texto não apenas oferece uma visão abrangente da FPI, mas também propõe novos horizontes terapêuticos focados em melhorar a qualidade de vida dos pacientes. Este trabalho contribui para o diálogo científico sobre a doença e sugere caminhos promissores para a pesquisa e o tratamento.
Downloads
Referências
Angelini, A., Trial, J., Ortiz-Urbina, J. y Cieslik, K. A. (2020). Mechanosensing dysregulation in the fibroblast: A hallmark of the aging heart. Ageing Research Reviews, 63, 101150. https://doi.org/10.1016/j.arr.2020.101150.
Angelini, A., Trial, J., Saltzman, A. B., Malovannaya, A. y Cieslik, K. A. (2023). A defective mechanosensing pathway affects fibroblast-to-myofibroblast transition in the old male mouse heart. iScience, 26(8), 107283. https://doi.org/10.1016/j.isci.2023.107283.
Balderas-Martínez, Y. I., Rinaldi, F., Contreras, G., Solano-Lira, H., Sánchez-Pérez, M., Collado-Vides, J., Selman, M. y Pardo, A. (2017). Improving biocuration of microRNAs in diseases: A case study in idiopathic pulmonary fibrosis. Database (Oxford), bax030. https://doi.org/10.1093/database/bax030.
Barratt, S. L., Creamer, A., Hayton, C. y Chaudhuri, N. (2018). Idiopathic pulmonary fibrosis (IPF): An overview. Journal of Clinical Medicine, 7(8), 201. https://doi.org/10.3390/jcm7080201.
Bueno, M., Lai, Y. C., Romero, Y., Brands, J., St Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., Duncan, S. R., Rojas, M., Shiva, S., Chu, C. T. y Mora, A. L. (2015). PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. Journal of Clinical Investigation, 125(2), 521-538. https://doi.org/10.1172/JCI74942.
Bueno, M., Calyeca, J., Rojas, M. y Mora, A. L. (2020). Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis. Redox Biology, 33, 101509. https://doi.org/10.1016/j.redox.2020.101509.
Burgstaller, G., Oehrle, B., Gerckens, M., White, E. S., Schiller, H. B. y Eickelberg, O. (2017). The instructive extracellular matrix of the lung: Basic composition and alterations in chronic lung disease. European Respiratory Journal, 50(1), 1601805. https://doi.org/10.1183/13993003.01805-2016.
Cabrera, S., Maciel, M., Herrera, I., Nava, T., Vergara, F., Gaxiola, M., López-Otín, C., Selman, M. y Pardo, A. (2015). Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis. Autophagy, 11(4), 670-684. https://doi.org/10.1080/15548627.2015.1034409.
Cabrera, S., Rodríguez-Bobadilla, C., Vázquez-Morales, D., Gaxiola, M., Maciel, M., Selman, M. y Pardo, A. (2020). Identification of autophagy-related proteins in lungs from hypersensitivity pneumonitis patients. Journal of Histochemistry & Cytochemistry, 68(6), 365-376. https://doi.org/10.1369/0022155420932103.
Cabrera, S., García-Vicente, Á., Gutiérrez, P., Sánchez, A., Gaxiola, M., Rodríguez-Bobadilla, C., Selman, M. y Pardo, A. (2024). Increased ER stress and unfolded protein response activation in epithelial and inflammatory cells in hypersensitivity pneumonitis. Journal of Histochemistry & Cytochemistry, 72(5), 289-307. https://doi.org/10.1369/00221554241251915.
Domínguez, L. J., Veronese, N., Vernuccio, L., Catanese, G., Inzerillo, F., Salemi, G. y Barbagallo, M. (2021). Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia. Nutrients, 13(11), 4080. https://doi.org/10.3390/nu13114080.
Faverio, P., Bocchino, M., Caminati, A., Fumagalli, A., Gasbarra, M., Iovino, P., Petruzzi, A., Scalfi, L., Sebastiani, A., Stanziola, A. A. y Sanduzzi, A. (2020). Nutrition in patients with idiopathic pulmonary fibrosis: Critical issues analysis and future research directions. Nutrients, 12(4), 1131. https://doi.org/10.3390/nu12041131.
Ganslandt, C., Maher, T. M., Molyneaux, P. L., Lindmark, B. E., Raud, J., Tornling, G., Bengtsson, T. y Rosendahl, E. (2024). Buloxibutid, a novel angiotensin II type 2 receptor agonist, stabilized and improved lung function in individuals with idiopathic pulmonary fibrosis in the 36-week Phase 2 AIR trial [Resumen]. American Journal of Respiratory and Critical Care Medicine, 209(1), A1055. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1055.
Huang, X., Yang, N., Fiore, V. F., Barker, T. H., Sun, Y., Morris, S. W., Ding, Q., Thannickal, V. J. y Zhou, Y. (2012). Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. American Journal of Respiratory Cell and Molecular Biology, 47(3), 340-348. https://doi.org/10.1165/rcmb.2012-0050OC.
Khor, Y. H., Bissell, B., Ghazipura, M., Herman, D., Hon, S. M., Hossain, T., Kheir, F., Knight, S. L., Kreuter, M., Macrea, M., Mammen, J., Molina-Molina, M., Selman, M., Wijsenbeek, M., Raghu, G. y Wilson, K. C. (2022). Antacid medication and antireflux surgery in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Annals of the American Thoracic Society, 19(5), 833-844. https://doi.org/10.1513/AnnalsATS.202102-172OC.
Li, W., Kawaguchi, K., Tanaka, S., He, C., Maeshima, Y., Suzuki, E. y Toi, M. (2023). Cellular senescence triggers intracelular acidification and lysosomal pH alkalinized via ATP6AP2 attenuation in breast cancer cells. Communications Biology, 6(1), 1147. https://doi.org/10.1038/s42003-023-05433-6.
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. y Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194-1217. https://doi.org/10.1016/j.cell.2013.05.039.
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. y Kroemer, G. (2023). Hallmarks of aging: An expanding universe. Cell, 186(2), 243-278. https://doi.org/10.1016/j.cell.2022.11.001.
Luis-García, E. R., Becerril, C., Salgado-Aguayo, A., Aparicio-Trejo, O. E., Romero, Y., Flores-Soto, E., Mendoza-Milla, C., Montaño, M., Chagoya, V., Pedraza-Chaverri, J., El Hafidi, M., Orozco-Ibarra, M., Pardo, A. y Selman, M. (2021). Mitochondrial dysfunction and alterations in mitochondrial permeability transition pore (mPTP) contribute to apoptosis resistance in idiopathic pulmonary fibrosis fibroblasts. International Journal of Molecular Sciences, 22(15), 7870. https://doi.org/10.3390/ijms22157870.
Maciel, M., Hernández-Barrientos, D., Herrera, I., Selman, M., Pardo, A. y Cabrera, S. (2018). Impaired autophagic activity and ATG4B deficiency are associated with increased endoplasmic reticulum stress-induced lung injury. Aging, 10(8), 2098-2112. https://doi.org/10.18632/aging.101532.
Maher, T. M., Goldin, G. J., DiFrancesco, A., de los Ríos, M., Quito, C., Kim, S., Frohna, P. A. y Hood, J. (2024, 19 de mayo). ENV-101, a novel hedgehog inhibitor, increases lung function, and reduces lung fibrosis in patients with idiopathic pulmonary fibrosis: Results from a randomized, double-blind, placebo-controlled Phase 2 trial [Resumen]. American Journal of Respiratory and Critical Care Medicine, 209(1), A1056. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A1056.
Mebratu, Y. A., Soni, S., Rosas, L., Rojas, M., Horowitz, J. C. y Nho, R. (2023). The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype. American Journal of Physiology. Cell Physiology, 325(3), C565-C579. https://doi.org/10.1152/ajpcell.00124.2023.
Molina-Molina, M. (2008). Clasificación de las enfermedades pulmonares intersticiales difusas: Interpretación clínico-terapéutica y actualización. Medicina Respiratoria, 1(1), 39-47. http://www.neumologiaysalud.es/descargas/R1/R1-5.pdf.
Montes, E., Buendía-Roldán, I., Díaz-Piña, G., Moreno-Ávila, V. y Ruiz, V. (2019). Evaluation of renin and soluble (pro) renin receptor in patients with IPF. A comparison with hypersensitivity pneumonitis. Lung, 197(6), 715-720. https://doi.org/10.1007/s00408-019-00278-5.
Mullard, A. (2022). Pliant’s integrin inhibitor boosted by phase II IPF data. Nature Reviews Drug Discovery, 21(9), 626. https://doi.org/10.1038/d41573-022-00135-w.
Negreros, M., Hagood, J. S., Espinoza, C. R., Balderas-Martínez, Y. I., Selman, M. y Pardo, A. (2019). Transforming growth factor beta 1 induces methylation changes in lung fibroblasts. PLoS ONE, 14(10), e0223512. https://doi.org/10.1371/journal.pone.0223512.
Ortíz-Quintero, B., Buendía-Roldán, I., Ramírez-Salazar, E. G., Balderas-Martínez, Y. I., Ramírez-Rodríguez, S. L., Martínez-Espinosa, K. y Selman, M. (2020). Circulating microRNA signature associated with interstitial lung abnormalities in respiratory asymptomatic subjects. Cells, 9(6), 1556. https://doi.org/10.3390/cells9061556.
Pardo, A., Cabrera, S., Maldonado, M. y Selman, M. (2016). Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respiratory Research, 17. https://doi.org/10.1186/s12931-016-0343-6.
Pardo, A. y Selman, M. (2021). The interplay of the genetic architecture, aging, and environmental factors in the pathogenesis of idiopathic pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology, 64(2), 163-172. https://doi.org/10.1165/rcmb.2020-0373PS.
Qu, J., Yang, S.-Z., Zhu, Y., Guo, T., Thannickal, V. J. y Zhou, Y. (2021). Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice. Journal of Experimental Medicine, 218(5), Article e20202033. https://doi.org/10.1084/jem.20202033.
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., Johkoh, T., Martinez, F. J., Myers, J., Protzko, S. L., Richeldi, L., Rind, D., Selman, M., Theodore, A., Wells, A. U., ... Schünemann, H. J. (2015). An official ATS/ERS/JRS/ALAT clinical practice guideline: Treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 192(2), e3-e19. https://doi.org/10.1164/rccm.201506-1063ST.
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., Mazula, D. L., Brooks, R. W., Fuhrmann-Stroissnigg, H., Pirtskhalava, T., Prakash, Y. S., Tchkonia, T., Robbins, P. D., Aubry, M. C., ... LeBrasseur, N. K. (2017). Cellular senescence mediates fibrotic pulmonary disease. Nature Communications, 8, 14532. https://doi.org/10.1038/ncomms14532.
Schilter, H., Findlay, A. D., Perryman, L., Yow, T. T., Moses, J., Zahoor, A., Turner, C. I., Deodhar, M., Foot, J. S., Zhou, W., Greco, A., Joshi, A., Rayner, B., Townsend, S., Buson, A. y Jarolimek, W. (2019). The lysyl oxidase-like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. Journal of Cellular and Molecular Medicine, 23(3), 1759-1770.https://doi.org/10.1111/jcmm.14074.
Schmauck-Medina, T., Molière, A., Lautrup, S., Zhang, J., Chlopicki, S., Madsen, H. B., Cao, S., Soendenbroe, C., Mansell, E., Vestergaard, M. B., Li, Z., Shiloh, Y., Opresko, P. L., Egly, J. M., Kirkwood, T., Verdin, E., Bohr, V. A., Cox, L. S., Stevnsner, T., ... Fang, E. F. (2022). New hallmarks of ageing: A 2022 Copenhagen ageing meeting summary. Aging, 14(16), 6829-6839.https://doi.org/10.18632/aging.204248.
Torres-Machorro, A. L., Becerril, C., Hernández-Plata, E., Luis-García, E. R., Maldonado, M., Herrera, I., Negreros, M., Hernández-Sánchez, F., Mendoza-Milla, C., Gaxiola, M., Ramírez, R., Pardo, A., Buendía-Roldán, I., Selman, M. y Cisneros, J. (2024). Altered expression pattern of immune response-related genes and isoforms in hypersensitivity pneumonitis lung fibroblasts. Scientific Reports, 14, 24002 (2024). https://doi.org/10.1038/s41598-024-74267-x.
Toscano-Márquez, F., Romero, Y., Espina-Ordóñez, M. y Cisneros, J. (2023). Absence of HDAC3 by matrix stiffness promotes chromatin remodeling and fibroblast activation in idiopathic pulmonary fibrosis. Cells, 12(7), Article 1020. https://doi.org/10.3390/cells12071020.
Zhu, Y., Prata, L. G. P. L., Gerdes, E. O. W., Netto, J. M. E., Pirtskhalava, T., Giorgadze, N., Tripathi, U., Inman, C. L., Johnson, K. O., Xue, A., Palmer, A. K., Chen, T., Schaefer, K., Justice, J. N., Nambiar, A. M., Musi, N., Kritchevsky, S. B., Chen, J., ... Kirkland, J. L. (2022). Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans. EBioMedicine, 77, 103912. https://doi.org/10.1016/j.ebiom.2022.103912.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2024 Entretextos
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
